Pharma & Healthcare
Global Opioid Induced Constipation (OIC) Drugs Market Research Report 2025
- Nov 04, 25
- ID: 480503
- Pages: 103
- Figures: 99
- Views: 13
Report Scope
This report aims to provide a comprehensive presentation of the global market for Opioid Induced Constipation (OIC) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opioid Induced Constipation (OIC) Drugs.
The Opioid Induced Constipation (OIC) Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Opioid Induced Constipation (OIC) Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, Route of Administration and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Opioid Induced Constipation (OIC) Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, Route of Administration and by regions.
By Company
Takeda Pharmaceuticals
Bayer
Sanofi
Mallinckrodt
Salix (Bausch Health)
AstraZeneca
Progenics Pharmaceuticals
Purdue Pharm
Nektar Therapeutics
Daiichi Sankyo
Prestige
GSK
Shionogi
Bausch Health
Zentiva
Orifarm A/S
Viatris
Endo International
Zhengdatianqing
Segment by Type
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Others
Segment Route of Administration
Oral Formulations
Injectable Formulations
Suppositories / Enemas
Other
Segment Chemical Class
Peripheral µ-opioid Receptor Antagonists,
Prokinetic Agents
Bulk-forming Laxatives
Other
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Opioid Induced Constipation (OIC) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Opioid Induced Constipation (OIC) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Opioid Induced Constipation (OIC) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opioid Induced Constipation (OIC) Drugs.
The Opioid Induced Constipation (OIC) Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Opioid Induced Constipation (OIC) Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, Route of Administration and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Opioid Induced Constipation (OIC) Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, Route of Administration and by regions.
By Company
Takeda Pharmaceuticals
Bayer
Sanofi
Mallinckrodt
Salix (Bausch Health)
AstraZeneca
Progenics Pharmaceuticals
Purdue Pharm
Nektar Therapeutics
Daiichi Sankyo
Prestige
GSK
Shionogi
Bausch Health
Zentiva
Orifarm A/S
Viatris
Endo International
Zhengdatianqing
Segment by Type
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Others
Segment Route of Administration
Oral Formulations
Injectable Formulations
Suppositories / Enemas
Other
Segment Chemical Class
Peripheral µ-opioid Receptor Antagonists,
Prokinetic Agents
Bulk-forming Laxatives
Other
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Opioid Induced Constipation (OIC) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Opioid Induced Constipation (OIC) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Opioid Induced Constipation (OIC) Drugs Market Overview
1.1 Product Definition
1.2 Opioid Induced Constipation (OIC) Drugs by Type
1.2.1 Global Opioid Induced Constipation (OIC) Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Lubiprostone
1.2.3 Methyl Naltrexone Bromide
1.2.4 Naldemedine
1.2.5 Alvimopan
1.2.6 Others
1.3 Opioid Induced Constipation (OIC) Drugs Route of Administration
1.3.1 Global Opioid Induced Constipation (OIC) Drugs Market Value Comparison Route of Administration: 2024 VS 2031
1.3.2 Oral Formulations
1.3.3 Injectable Formulations
1.3.4 Suppositories / Enemas
1.3.5 Other
1.4 Opioid Induced Constipation (OIC) Drugs Chemical Class
1.4.1 Global Opioid Induced Constipation (OIC) Drugs Market Value Comparison Chemical Class: 2024 VS 2031
1.4.2 Peripheral µ-opioid Receptor Antagonists,
1.4.3 Prokinetic Agents
1.4.4 Bulk-forming Laxatives
1.4.5 Other
1.5 Opioid Induced Constipation (OIC) Drugs by Application
1.5.1 Global Opioid Induced Constipation (OIC) Drugs Market Value by Application (2024 VS 2031)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Global Opioid Induced Constipation (OIC) Drugs Market Size Estimates and Forecasts
1.6.1 Global Opioid Induced Constipation (OIC) Drugs Revenue 2020-2031
1.6.2 Global Opioid Induced Constipation (OIC) Drugs Sales 2020-2031
1.6.3 Global Opioid Induced Constipation (OIC) Drugs Market Average Price (2020-2031)
1.7 Assumptions and Limitations
2 Opioid Induced Constipation (OIC) Drugs Market Competition by Manufacturers
2.1 Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Opioid Induced Constipation (OIC) Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Opioid Induced Constipation (OIC) Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Opioid Induced Constipation (OIC) Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Opioid Induced Constipation (OIC) Drugs, Product Type & Application
2.7 Global Key Manufacturers of Opioid Induced Constipation (OIC) Drugs, Date of Enter into This Industry
2.8 Global Opioid Induced Constipation (OIC) Drugs Market Competitive Situation and Trends
2.8.1 Global Opioid Induced Constipation (OIC) Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Opioid Induced Constipation (OIC) Drugs Players Market Share by Revenue
2.8.3 Global Opioid Induced Constipation (OIC) Drugs Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Opioid Induced Constipation (OIC) Drugs Market Scenario by Region
3.1 Global Opioid Induced Constipation (OIC) Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Opioid Induced Constipation (OIC) Drugs Sales by Region: 2020-2031
3.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales by Region: 2020-2025
3.2.2 Global Opioid Induced Constipation (OIC) Drugs Sales by Region: 2026-2031
3.3 Global Opioid Induced Constipation (OIC) Drugs Revenue by Region: 2020-2031
3.3.1 Global Opioid Induced Constipation (OIC) Drugs Revenue by Region: 2020-2025
3.3.2 Global Opioid Induced Constipation (OIC) Drugs Revenue by Region: 2026-2031
3.4 North America Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Country
3.4.1 North America Opioid Induced Constipation (OIC) Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Opioid Induced Constipation (OIC) Drugs Sales by Country (2020-2031)
3.4.3 North America Opioid Induced Constipation (OIC) Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Country
3.5.1 Europe Opioid Induced Constipation (OIC) Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Opioid Induced Constipation (OIC) Drugs Sales by Country (2020-2031)
3.5.3 Europe Opioid Induced Constipation (OIC) Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Opioid Induced Constipation (OIC) Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Opioid Induced Constipation (OIC) Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Country
3.7.1 Latin America Opioid Induced Constipation (OIC) Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Opioid Induced Constipation (OIC) Drugs Sales by Country (2020-2031)
3.7.3 Latin America Opioid Induced Constipation (OIC) Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Opioid Induced Constipation (OIC) Drugs Sales by Type (2020-2031)
4.1.1 Global Opioid Induced Constipation (OIC) Drugs Sales by Type (2020-2025)
4.1.2 Global Opioid Induced Constipation (OIC) Drugs Sales by Type (2026-2031)
4.1.3 Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2020-2031)
4.2 Global Opioid Induced Constipation (OIC) Drugs Revenue by Type (2020-2031)
4.2.1 Global Opioid Induced Constipation (OIC) Drugs Revenue by Type (2020-2025)
4.2.2 Global Opioid Induced Constipation (OIC) Drugs Revenue by Type (2026-2031)
4.2.3 Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Opioid Induced Constipation (OIC) Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Opioid Induced Constipation (OIC) Drugs Sales by Application (2020-2031)
5.1.1 Global Opioid Induced Constipation (OIC) Drugs Sales by Application (2020-2025)
5.1.2 Global Opioid Induced Constipation (OIC) Drugs Sales by Application (2026-2031)
5.1.3 Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2020-2031)
5.2 Global Opioid Induced Constipation (OIC) Drugs Revenue by Application (2020-2031)
5.2.1 Global Opioid Induced Constipation (OIC) Drugs Revenue by Application (2020-2025)
5.2.2 Global Opioid Induced Constipation (OIC) Drugs Revenue by Application (2026-2031)
5.2.3 Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Opioid Induced Constipation (OIC) Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Takeda Pharmaceuticals
6.1.1 Takeda Pharmaceuticals Company Information
6.1.2 Takeda Pharmaceuticals Description and Business Overview
6.1.3 Takeda Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Takeda Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.1.5 Takeda Pharmaceuticals Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Company Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bayer Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sanofi Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Mallinckrodt
6.4.1 Mallinckrodt Company Information
6.4.2 Mallinckrodt Description and Business Overview
6.4.3 Mallinckrodt Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Mallinckrodt Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.4.5 Mallinckrodt Recent Developments/Updates
6.5 Salix (Bausch Health)
6.5.1 Salix (Bausch Health) Company Information
6.5.2 Salix (Bausch Health) Description and Business Overview
6.5.3 Salix (Bausch Health) Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Salix (Bausch Health) Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.5.5 Salix (Bausch Health) Recent Developments/Updates
6.6 AstraZeneca
6.6.1 AstraZeneca Company Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 AstraZeneca Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.6.5 AstraZeneca Recent Developments/Updates
6.7 Progenics Pharmaceuticals
6.7.1 Progenics Pharmaceuticals Company Information
6.7.2 Progenics Pharmaceuticals Description and Business Overview
6.7.3 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.7.5 Progenics Pharmaceuticals Recent Developments/Updates
6.8 Purdue Pharm
6.8.1 Purdue Pharm Company Information
6.8.2 Purdue Pharm Description and Business Overview
6.8.3 Purdue Pharm Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Purdue Pharm Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.8.5 Purdue Pharm Recent Developments/Updates
6.9 Nektar Therapeutics
6.9.1 Nektar Therapeutics Company Information
6.9.2 Nektar Therapeutics Description and Business Overview
6.9.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.9.5 Nektar Therapeutics Recent Developments/Updates
6.10 Daiichi Sankyo
6.10.1 Daiichi Sankyo Company Information
6.10.2 Daiichi Sankyo Description and Business Overview
6.10.3 Daiichi Sankyo Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Daiichi Sankyo Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.10.5 Daiichi Sankyo Recent Developments/Updates
6.11 Prestige
6.11.1 Prestige Company Information
6.11.2 Prestige Description and Business Overview
6.11.3 Prestige Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Prestige Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.11.5 Prestige Recent Developments/Updates
6.12 GSK
6.12.1 GSK Company Information
6.12.2 GSK Description and Business Overview
6.12.3 GSK Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 GSK Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.12.5 GSK Recent Developments/Updates
6.13 Shionogi
6.13.1 Shionogi Company Information
6.13.2 Shionogi Description and Business Overview
6.13.3 Shionogi Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Shionogi Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.13.5 Shionogi Recent Developments/Updates
6.14 Bausch Health
6.14.1 Bausch Health Company Information
6.14.2 Bausch Health Description and Business Overview
6.14.3 Bausch Health Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Bausch Health Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.14.5 Bausch Health Recent Developments/Updates
6.15 Zentiva
6.15.1 Zentiva Company Information
6.15.2 Zentiva Description and Business Overview
6.15.3 Zentiva Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Zentiva Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.15.5 Zentiva Recent Developments/Updates
6.16 Orifarm A/S
6.16.1 Orifarm A/S Company Information
6.16.2 Orifarm A/S Description and Business Overview
6.16.3 Orifarm A/S Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Orifarm A/S Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.16.5 Orifarm A/S Recent Developments/Updates
6.17 Viatris
6.17.1 Viatris Company Information
6.17.2 Viatris Description and Business Overview
6.17.3 Viatris Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Viatris Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.17.5 Viatris Recent Developments/Updates
6.18 Endo International
6.18.1 Endo International Company Information
6.18.2 Endo International Description and Business Overview
6.18.3 Endo International Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Endo International Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.18.5 Endo International Recent Developments/Updates
6.19 Zhengdatianqing
6.19.1 Zhengdatianqing Company Information
6.19.2 Zhengdatianqing Description and Business Overview
6.19.3 Zhengdatianqing Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Zhengdatianqing Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.19.5 Zhengdatianqing Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Opioid Induced Constipation (OIC) Drugs Industry Chain Analysis
7.2 Opioid Induced Constipation (OIC) Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Opioid Induced Constipation (OIC) Drugs Production Mode & Process Analysis
7.4 Opioid Induced Constipation (OIC) Drugs Sales and Marketing
7.4.1 Opioid Induced Constipation (OIC) Drugs Sales Channels
7.4.2 Opioid Induced Constipation (OIC) Drugs Distributors
7.5 Opioid Induced Constipation (OIC) Drugs Customer Analysis
8 Opioid Induced Constipation (OIC) Drugs Market Dynamics
8.1 Opioid Induced Constipation (OIC) Drugs Industry Trends
8.2 Opioid Induced Constipation (OIC) Drugs Market Drivers
8.3 Opioid Induced Constipation (OIC) Drugs Market Challenges
8.4 Opioid Induced Constipation (OIC) Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Opioid Induced Constipation (OIC) Drugs by Type
1.2.1 Global Opioid Induced Constipation (OIC) Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Lubiprostone
1.2.3 Methyl Naltrexone Bromide
1.2.4 Naldemedine
1.2.5 Alvimopan
1.2.6 Others
1.3 Opioid Induced Constipation (OIC) Drugs Route of Administration
1.3.1 Global Opioid Induced Constipation (OIC) Drugs Market Value Comparison Route of Administration: 2024 VS 2031
1.3.2 Oral Formulations
1.3.3 Injectable Formulations
1.3.4 Suppositories / Enemas
1.3.5 Other
1.4 Opioid Induced Constipation (OIC) Drugs Chemical Class
1.4.1 Global Opioid Induced Constipation (OIC) Drugs Market Value Comparison Chemical Class: 2024 VS 2031
1.4.2 Peripheral µ-opioid Receptor Antagonists,
1.4.3 Prokinetic Agents
1.4.4 Bulk-forming Laxatives
1.4.5 Other
1.5 Opioid Induced Constipation (OIC) Drugs by Application
1.5.1 Global Opioid Induced Constipation (OIC) Drugs Market Value by Application (2024 VS 2031)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Global Opioid Induced Constipation (OIC) Drugs Market Size Estimates and Forecasts
1.6.1 Global Opioid Induced Constipation (OIC) Drugs Revenue 2020-2031
1.6.2 Global Opioid Induced Constipation (OIC) Drugs Sales 2020-2031
1.6.3 Global Opioid Induced Constipation (OIC) Drugs Market Average Price (2020-2031)
1.7 Assumptions and Limitations
2 Opioid Induced Constipation (OIC) Drugs Market Competition by Manufacturers
2.1 Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Opioid Induced Constipation (OIC) Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Opioid Induced Constipation (OIC) Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Opioid Induced Constipation (OIC) Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Opioid Induced Constipation (OIC) Drugs, Product Type & Application
2.7 Global Key Manufacturers of Opioid Induced Constipation (OIC) Drugs, Date of Enter into This Industry
2.8 Global Opioid Induced Constipation (OIC) Drugs Market Competitive Situation and Trends
2.8.1 Global Opioid Induced Constipation (OIC) Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Opioid Induced Constipation (OIC) Drugs Players Market Share by Revenue
2.8.3 Global Opioid Induced Constipation (OIC) Drugs Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Opioid Induced Constipation (OIC) Drugs Market Scenario by Region
3.1 Global Opioid Induced Constipation (OIC) Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Opioid Induced Constipation (OIC) Drugs Sales by Region: 2020-2031
3.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales by Region: 2020-2025
3.2.2 Global Opioid Induced Constipation (OIC) Drugs Sales by Region: 2026-2031
3.3 Global Opioid Induced Constipation (OIC) Drugs Revenue by Region: 2020-2031
3.3.1 Global Opioid Induced Constipation (OIC) Drugs Revenue by Region: 2020-2025
3.3.2 Global Opioid Induced Constipation (OIC) Drugs Revenue by Region: 2026-2031
3.4 North America Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Country
3.4.1 North America Opioid Induced Constipation (OIC) Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Opioid Induced Constipation (OIC) Drugs Sales by Country (2020-2031)
3.4.3 North America Opioid Induced Constipation (OIC) Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Country
3.5.1 Europe Opioid Induced Constipation (OIC) Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Opioid Induced Constipation (OIC) Drugs Sales by Country (2020-2031)
3.5.3 Europe Opioid Induced Constipation (OIC) Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Opioid Induced Constipation (OIC) Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Opioid Induced Constipation (OIC) Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Country
3.7.1 Latin America Opioid Induced Constipation (OIC) Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Opioid Induced Constipation (OIC) Drugs Sales by Country (2020-2031)
3.7.3 Latin America Opioid Induced Constipation (OIC) Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Opioid Induced Constipation (OIC) Drugs Sales by Type (2020-2031)
4.1.1 Global Opioid Induced Constipation (OIC) Drugs Sales by Type (2020-2025)
4.1.2 Global Opioid Induced Constipation (OIC) Drugs Sales by Type (2026-2031)
4.1.3 Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2020-2031)
4.2 Global Opioid Induced Constipation (OIC) Drugs Revenue by Type (2020-2031)
4.2.1 Global Opioid Induced Constipation (OIC) Drugs Revenue by Type (2020-2025)
4.2.2 Global Opioid Induced Constipation (OIC) Drugs Revenue by Type (2026-2031)
4.2.3 Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Opioid Induced Constipation (OIC) Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Opioid Induced Constipation (OIC) Drugs Sales by Application (2020-2031)
5.1.1 Global Opioid Induced Constipation (OIC) Drugs Sales by Application (2020-2025)
5.1.2 Global Opioid Induced Constipation (OIC) Drugs Sales by Application (2026-2031)
5.1.3 Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2020-2031)
5.2 Global Opioid Induced Constipation (OIC) Drugs Revenue by Application (2020-2031)
5.2.1 Global Opioid Induced Constipation (OIC) Drugs Revenue by Application (2020-2025)
5.2.2 Global Opioid Induced Constipation (OIC) Drugs Revenue by Application (2026-2031)
5.2.3 Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Opioid Induced Constipation (OIC) Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Takeda Pharmaceuticals
6.1.1 Takeda Pharmaceuticals Company Information
6.1.2 Takeda Pharmaceuticals Description and Business Overview
6.1.3 Takeda Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Takeda Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.1.5 Takeda Pharmaceuticals Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Company Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bayer Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sanofi Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Mallinckrodt
6.4.1 Mallinckrodt Company Information
6.4.2 Mallinckrodt Description and Business Overview
6.4.3 Mallinckrodt Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Mallinckrodt Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.4.5 Mallinckrodt Recent Developments/Updates
6.5 Salix (Bausch Health)
6.5.1 Salix (Bausch Health) Company Information
6.5.2 Salix (Bausch Health) Description and Business Overview
6.5.3 Salix (Bausch Health) Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Salix (Bausch Health) Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.5.5 Salix (Bausch Health) Recent Developments/Updates
6.6 AstraZeneca
6.6.1 AstraZeneca Company Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 AstraZeneca Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.6.5 AstraZeneca Recent Developments/Updates
6.7 Progenics Pharmaceuticals
6.7.1 Progenics Pharmaceuticals Company Information
6.7.2 Progenics Pharmaceuticals Description and Business Overview
6.7.3 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.7.5 Progenics Pharmaceuticals Recent Developments/Updates
6.8 Purdue Pharm
6.8.1 Purdue Pharm Company Information
6.8.2 Purdue Pharm Description and Business Overview
6.8.3 Purdue Pharm Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Purdue Pharm Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.8.5 Purdue Pharm Recent Developments/Updates
6.9 Nektar Therapeutics
6.9.1 Nektar Therapeutics Company Information
6.9.2 Nektar Therapeutics Description and Business Overview
6.9.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.9.5 Nektar Therapeutics Recent Developments/Updates
6.10 Daiichi Sankyo
6.10.1 Daiichi Sankyo Company Information
6.10.2 Daiichi Sankyo Description and Business Overview
6.10.3 Daiichi Sankyo Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Daiichi Sankyo Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.10.5 Daiichi Sankyo Recent Developments/Updates
6.11 Prestige
6.11.1 Prestige Company Information
6.11.2 Prestige Description and Business Overview
6.11.3 Prestige Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Prestige Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.11.5 Prestige Recent Developments/Updates
6.12 GSK
6.12.1 GSK Company Information
6.12.2 GSK Description and Business Overview
6.12.3 GSK Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 GSK Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.12.5 GSK Recent Developments/Updates
6.13 Shionogi
6.13.1 Shionogi Company Information
6.13.2 Shionogi Description and Business Overview
6.13.3 Shionogi Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Shionogi Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.13.5 Shionogi Recent Developments/Updates
6.14 Bausch Health
6.14.1 Bausch Health Company Information
6.14.2 Bausch Health Description and Business Overview
6.14.3 Bausch Health Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Bausch Health Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.14.5 Bausch Health Recent Developments/Updates
6.15 Zentiva
6.15.1 Zentiva Company Information
6.15.2 Zentiva Description and Business Overview
6.15.3 Zentiva Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Zentiva Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.15.5 Zentiva Recent Developments/Updates
6.16 Orifarm A/S
6.16.1 Orifarm A/S Company Information
6.16.2 Orifarm A/S Description and Business Overview
6.16.3 Orifarm A/S Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Orifarm A/S Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.16.5 Orifarm A/S Recent Developments/Updates
6.17 Viatris
6.17.1 Viatris Company Information
6.17.2 Viatris Description and Business Overview
6.17.3 Viatris Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Viatris Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.17.5 Viatris Recent Developments/Updates
6.18 Endo International
6.18.1 Endo International Company Information
6.18.2 Endo International Description and Business Overview
6.18.3 Endo International Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Endo International Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.18.5 Endo International Recent Developments/Updates
6.19 Zhengdatianqing
6.19.1 Zhengdatianqing Company Information
6.19.2 Zhengdatianqing Description and Business Overview
6.19.3 Zhengdatianqing Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Zhengdatianqing Opioid Induced Constipation (OIC) Drugs Product Portfolio
6.19.5 Zhengdatianqing Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Opioid Induced Constipation (OIC) Drugs Industry Chain Analysis
7.2 Opioid Induced Constipation (OIC) Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Opioid Induced Constipation (OIC) Drugs Production Mode & Process Analysis
7.4 Opioid Induced Constipation (OIC) Drugs Sales and Marketing
7.4.1 Opioid Induced Constipation (OIC) Drugs Sales Channels
7.4.2 Opioid Induced Constipation (OIC) Drugs Distributors
7.5 Opioid Induced Constipation (OIC) Drugs Customer Analysis
8 Opioid Induced Constipation (OIC) Drugs Market Dynamics
8.1 Opioid Induced Constipation (OIC) Drugs Industry Trends
8.2 Opioid Induced Constipation (OIC) Drugs Market Drivers
8.3 Opioid Induced Constipation (OIC) Drugs Market Challenges
8.4 Opioid Induced Constipation (OIC) Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Opioid Induced Constipation (OIC) Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Opioid Induced Constipation (OIC) Drugs Market Value Route of Administration, (US$ Million) & (2024 VS 2031)
Table 3. Global Opioid Induced Constipation (OIC) Drugs Market Value Chemical Class, (US$ Million) & (2024 VS 2031)
Table 4. Global Opioid Induced Constipation (OIC) Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 5. Global Opioid Induced Constipation (OIC) Drugs Market Competitive Situation by Manufacturers in 2024
Table 6. Global Opioid Induced Constipation (OIC) Drugs Sales (K Dose) of Key Manufacturers (2020-2025)
Table 7. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Opioid Induced Constipation (OIC) Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 9. Global Opioid Induced Constipation (OIC) Drugs Revenue Share by Manufacturers (2020-2025)
Table 10. Global Market Opioid Induced Constipation (OIC) Drugs Average Price (USD/Dose) of Key Manufacturers (2020-2025)
Table 11. Global Key Players of Opioid Induced Constipation (OIC) Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 12. Global Key Manufacturers of Opioid Induced Constipation (OIC) Drugs, Manufacturing Sites & Headquarters
Table 13. Global Key Manufacturers of Opioid Induced Constipation (OIC) Drugs, Product Type & Application
Table 14. Global Key Manufacturers of Opioid Induced Constipation (OIC) Drugs, Date of Enter into This Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Opioid Induced Constipation (OIC) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Induced Constipation (OIC) Drugs as of 2024)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Opioid Induced Constipation (OIC) Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 19. Global Opioid Induced Constipation (OIC) Drugs Sales by Region (2020-2025) & (K Dose)
Table 20. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Region (2020-2025)
Table 21. Global Opioid Induced Constipation (OIC) Drugs Sales by Region (2026-2031) & (K Dose)
Table 22. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Region (2026-2031)
Table 23. Global Opioid Induced Constipation (OIC) Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 24. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Region (2020-2025)
Table 25. Global Opioid Induced Constipation (OIC) Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 26. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Region (2026-2031)
Table 27. North America Opioid Induced Constipation (OIC) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. North America Opioid Induced Constipation (OIC) Drugs Sales by Country (2020-2025) & (K Dose)
Table 29. North America Opioid Induced Constipation (OIC) Drugs Sales by Country (2026-2031) & (K Dose)
Table 30. North America Opioid Induced Constipation (OIC) Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 31. North America Opioid Induced Constipation (OIC) Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 32. Europe Opioid Induced Constipation (OIC) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 33. Europe Opioid Induced Constipation (OIC) Drugs Sales by Country (2020-2025) & (K Dose)
Table 34. Europe Opioid Induced Constipation (OIC) Drugs Sales by Country (2026-2031) & (K Dose)
Table 35. Europe Opioid Induced Constipation (OIC) Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 36. Europe Opioid Induced Constipation (OIC) Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 37. Asia Pacific Opioid Induced Constipation (OIC) Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 38. Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales by Region (2020-2025) & (K Dose)
Table 39. Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales by Region (2026-2031) & (K Dose)
Table 40. Asia Pacific Opioid Induced Constipation (OIC) Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 41. Asia Pacific Opioid Induced Constipation (OIC) Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 42. Latin America Opioid Induced Constipation (OIC) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Latin America Opioid Induced Constipation (OIC) Drugs Sales by Country (2020-2025) & (K Dose)
Table 44. Latin America Opioid Induced Constipation (OIC) Drugs Sales by Country (2026-2031) & (K Dose)
Table 45. Latin America Opioid Induced Constipation (OIC) Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 46. Latin America Opioid Induced Constipation (OIC) Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 47. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 48. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales by Country (2020-2025) & (K Dose)
Table 49. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales by Country (2026-2031) & (K Dose)
Table 50. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 51. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 52. Global Opioid Induced Constipation (OIC) Drugs Sales (K Dose) by Type (2020-2025)
Table 53. Global Opioid Induced Constipation (OIC) Drugs Sales (K Dose) by Type (2026-2031)
Table 54. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2020-2025)
Table 55. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2026-2031)
Table 56. Global Opioid Induced Constipation (OIC) Drugs Revenue (US$ Million) by Type (2020-2025)
Table 57. Global Opioid Induced Constipation (OIC) Drugs Revenue (US$ Million) by Type (2026-2031)
Table 58. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Type (2020-2025)
Table 59. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Type (2026-2031)
Table 60. Global Opioid Induced Constipation (OIC) Drugs Price (USD/Dose) by Type (2020-2025)
Table 61. Global Opioid Induced Constipation (OIC) Drugs Price (USD/Dose) by Type (2026-2031)
Table 62. Global Opioid Induced Constipation (OIC) Drugs Sales (K Dose) by Application (2020-2025)
Table 63. Global Opioid Induced Constipation (OIC) Drugs Sales (K Dose) by Application (2026-2031)
Table 64. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2020-2025)
Table 65. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2026-2031)
Table 66. Global Opioid Induced Constipation (OIC) Drugs Revenue (US$ Million) by Application (2020-2025)
Table 67. Global Opioid Induced Constipation (OIC) Drugs Revenue (US$ Million) by Application (2026-2031)
Table 68. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Application (2020-2025)
Table 69. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Application (2026-2031)
Table 70. Global Opioid Induced Constipation (OIC) Drugs Price (USD/Dose) by Application (2020-2025)
Table 71. Global Opioid Induced Constipation (OIC) Drugs Price (USD/Dose) by Application (2026-2031)
Table 72. Takeda Pharmaceuticals Company Information
Table 73. Takeda Pharmaceuticals Description and Business Overview
Table 74. Takeda Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 75. Takeda Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product
Table 76. Takeda Pharmaceuticals Recent Developments/Updates
Table 77. Bayer Company Information
Table 78. Bayer Description and Business Overview
Table 79. Bayer Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 80. Bayer Opioid Induced Constipation (OIC) Drugs Product
Table 81. Bayer Recent Developments/Updates
Table 82. Sanofi Company Information
Table 83. Sanofi Description and Business Overview
Table 84. Sanofi Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 85. Sanofi Opioid Induced Constipation (OIC) Drugs Product
Table 86. Sanofi Recent Developments/Updates
Table 87. Mallinckrodt Company Information
Table 88. Mallinckrodt Description and Business Overview
Table 89. Mallinckrodt Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 90. Mallinckrodt Opioid Induced Constipation (OIC) Drugs Product
Table 91. Mallinckrodt Recent Developments/Updates
Table 92. Salix (Bausch Health) Company Information
Table 93. Salix (Bausch Health) Description and Business Overview
Table 94. Salix (Bausch Health) Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 95. Salix (Bausch Health) Opioid Induced Constipation (OIC) Drugs Product
Table 96. Salix (Bausch Health) Recent Developments/Updates
Table 97. AstraZeneca Company Information
Table 98. AstraZeneca Description and Business Overview
Table 99. AstraZeneca Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 100. AstraZeneca Opioid Induced Constipation (OIC) Drugs Product
Table 101. AstraZeneca Recent Developments/Updates
Table 102. Progenics Pharmaceuticals Company Information
Table 103. Progenics Pharmaceuticals Description and Business Overview
Table 104. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 105. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product
Table 106. Progenics Pharmaceuticals Recent Developments/Updates
Table 107. Purdue Pharm Company Information
Table 108. Purdue Pharm Description and Business Overview
Table 109. Purdue Pharm Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 110. Purdue Pharm Opioid Induced Constipation (OIC) Drugs Product
Table 111. Purdue Pharm Recent Developments/Updates
Table 112. Nektar Therapeutics Company Information
Table 113. Nektar Therapeutics Description and Business Overview
Table 114. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 115. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Product
Table 116. Nektar Therapeutics Recent Developments/Updates
Table 117. Daiichi Sankyo Company Information
Table 118. Daiichi Sankyo Description and Business Overview
Table 119. Daiichi Sankyo Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 120. Daiichi Sankyo Opioid Induced Constipation (OIC) Drugs Product
Table 121. Daiichi Sankyo Recent Developments/Updates
Table 122. Prestige Company Information
Table 123. Prestige Description and Business Overview
Table 124. Prestige Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 125. Prestige Opioid Induced Constipation (OIC) Drugs Product
Table 126. Prestige Recent Developments/Updates
Table 127. GSK Company Information
Table 128. GSK Description and Business Overview
Table 129. GSK Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 130. GSK Opioid Induced Constipation (OIC) Drugs Product
Table 131. GSK Recent Developments/Updates
Table 132. Shionogi Company Information
Table 133. Shionogi Description and Business Overview
Table 134. Shionogi Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 135. Shionogi Opioid Induced Constipation (OIC) Drugs Product
Table 136. Shionogi Recent Developments/Updates
Table 137. Bausch Health Company Information
Table 138. Bausch Health Description and Business Overview
Table 139. Bausch Health Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 140. Bausch Health Opioid Induced Constipation (OIC) Drugs Product
Table 141. Bausch Health Recent Developments/Updates
Table 142. Zentiva Company Information
Table 143. Zentiva Description and Business Overview
Table 144. Zentiva Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 145. Zentiva Opioid Induced Constipation (OIC) Drugs Product
Table 146. Zentiva Recent Developments/Updates
Table 147. Orifarm A/S Company Information
Table 148. Orifarm A/S Description and Business Overview
Table 149. Orifarm A/S Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 150. Orifarm A/S Opioid Induced Constipation (OIC) Drugs Product
Table 151. Orifarm A/S Recent Developments/Updates
Table 152. Viatris Company Information
Table 153. Viatris Description and Business Overview
Table 154. Viatris Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 155. Viatris Opioid Induced Constipation (OIC) Drugs Product
Table 156. Viatris Recent Developments/Updates
Table 157. Endo International Company Information
Table 158. Endo International Description and Business Overview
Table 159. Endo International Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 160. Endo International Opioid Induced Constipation (OIC) Drugs Product
Table 161. Endo International Recent Developments/Updates
Table 162. Zhengdatianqing Company Information
Table 163. Zhengdatianqing Description and Business Overview
Table 164. Zhengdatianqing Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 165. Zhengdatianqing Opioid Induced Constipation (OIC) Drugs Product
Table 166. Zhengdatianqing Recent Developments/Updates
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Opioid Induced Constipation (OIC) Drugs Distributors List
Table 170. Opioid Induced Constipation (OIC) Drugs Customers List
Table 171. Opioid Induced Constipation (OIC) Drugs Market Trends
Table 172. Opioid Induced Constipation (OIC) Drugs Market Drivers
Table 173. Opioid Induced Constipation (OIC) Drugs Market Challenges
Table 174. Opioid Induced Constipation (OIC) Drugs Market Restraints
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
Table 178. Authors List of This Report
List of Figures
Figure 1. Product Picture of Opioid Induced Constipation (OIC) Drugs
Figure 2. Global Opioid Induced Constipation (OIC) Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Opioid Induced Constipation (OIC) Drugs Market Share by Type: 2024 & 2031
Figure 4. Lubiprostone Product Picture
Figure 5. Methyl Naltrexone Bromide Product Picture
Figure 6. Naldemedine Product Picture
Figure 7. Alvimopan Product Picture
Figure 8. Others Product Picture
Figure 9. Global Opioid Induced Constipation (OIC) Drugs Market Value Route of Administration, (US$ Million) & (2020-2031)
Figure 10. Global Opioid Induced Constipation (OIC) Drugs Market Share Route of Administration: 2024 VS 2031
Figure 11. Oral Formulations Product Picture
Figure 12. Injectable Formulations Product Picture
Figure 13. Suppositories / Enemas Product Picture
Figure 14. Other Product Picture
Figure 15. Global Opioid Induced Constipation (OIC) Drugs Market Value Chemical Class, (US$ Million) & (2020-2031)
Figure 16. Global Opioid Induced Constipation (OIC) Drugs Market Share Chemical Class: 2024 VS 2031
Figure 17. Peripheral µ-opioid Receptor Antagonists, Product Picture
Figure 18. Prokinetic Agents Product Picture
Figure 19. Bulk-forming Laxatives Product Picture
Figure 20. Other Product Picture
Figure 21. Small Molecule Product Picture
Figure 22. Peptide Product Picture
Figure 23. Selective 5-HT4 Receptor Agonist Product Picture
Figure 24. Global Opioid Induced Constipation (OIC) Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 25. Global Opioid Induced Constipation (OIC) Drugs Market Share by Application: 2024 & 2031
Figure 26. Hospital Pharmacies
Figure 27. Retail Pharmacies
Figure 28. Online Pharmacies
Figure 29. Global Opioid Induced Constipation (OIC) Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 30. Global Opioid Induced Constipation (OIC) Drugs Market Size (2020-2031) & (US$ Million)
Figure 31. Global Opioid Induced Constipation (OIC) Drugs Sales (2020-2031) & (K Dose)
Figure 32. Global Opioid Induced Constipation (OIC) Drugs Average Price (USD/Dose) & (2020-2031)
Figure 33. Opioid Induced Constipation (OIC) Drugs Report Years Considered
Figure 34. Opioid Induced Constipation (OIC) Drugs Sales Share by Manufacturers in 2024
Figure 35. Global Opioid Induced Constipation (OIC) Drugs Revenue Share by Manufacturers in 2024
Figure 36. Global 5 and 10 Largest Opioid Induced Constipation (OIC) Drugs Players: Market Share by Revenue in Opioid Induced Constipation (OIC) Drugs in 2024
Figure 37. Opioid Induced Constipation (OIC) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 38. Global Opioid Induced Constipation (OIC) Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 39. North America Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country (2020-2031)
Figure 40. North America Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country (2020-2031)
Figure 41. U.S. Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Canada Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country (2020-2031)
Figure 44. Europe Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country (2020-2031)
Figure 45. Germany Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. France Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. U.K. Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Italy Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Russia Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales Market Share by Region (2020-2031)
Figure 51. Asia Pacific Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Region (2020-2031)
Figure 52. China Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Japan Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. South Korea Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. India Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Australia Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Taiwan Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Indonesia Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Thailand Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 60. Malaysia Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 61. Philippines Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 62. Latin America Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country (2020-2031)
Figure 63. Latin America Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country (2020-2031)
Figure 64. Mexico Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 65. Brazil Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 66. Argentina Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 67. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country (2020-2031)
Figure 68. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country (2020-2031)
Figure 69. Turkey Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 70. Saudi Arabia Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 71. U.A.E Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 72. Global Sales Market Share of Opioid Induced Constipation (OIC) Drugs by Type (2020-2031)
Figure 73. Global Revenue Market Share of Opioid Induced Constipation (OIC) Drugs by Type (2020-2031)
Figure 74. Global Opioid Induced Constipation (OIC) Drugs Price (USD/Dose) by Type (2020-2031)
Figure 75. Global Sales Market Share of Opioid Induced Constipation (OIC) Drugs by Application (2020-2031)
Figure 76. Global Revenue Market Share of Opioid Induced Constipation (OIC) Drugs by Application (2020-2031)
Figure 77. Global Opioid Induced Constipation (OIC) Drugs Price (USD/Dose) by Application (2020-2031)
Figure 78. Opioid Induced Constipation (OIC) Drugs Value Chain
Figure 79. Channels of Distribution (Direct Vs Distribution)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
Table 1. Global Opioid Induced Constipation (OIC) Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Opioid Induced Constipation (OIC) Drugs Market Value Route of Administration, (US$ Million) & (2024 VS 2031)
Table 3. Global Opioid Induced Constipation (OIC) Drugs Market Value Chemical Class, (US$ Million) & (2024 VS 2031)
Table 4. Global Opioid Induced Constipation (OIC) Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 5. Global Opioid Induced Constipation (OIC) Drugs Market Competitive Situation by Manufacturers in 2024
Table 6. Global Opioid Induced Constipation (OIC) Drugs Sales (K Dose) of Key Manufacturers (2020-2025)
Table 7. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Opioid Induced Constipation (OIC) Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 9. Global Opioid Induced Constipation (OIC) Drugs Revenue Share by Manufacturers (2020-2025)
Table 10. Global Market Opioid Induced Constipation (OIC) Drugs Average Price (USD/Dose) of Key Manufacturers (2020-2025)
Table 11. Global Key Players of Opioid Induced Constipation (OIC) Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 12. Global Key Manufacturers of Opioid Induced Constipation (OIC) Drugs, Manufacturing Sites & Headquarters
Table 13. Global Key Manufacturers of Opioid Induced Constipation (OIC) Drugs, Product Type & Application
Table 14. Global Key Manufacturers of Opioid Induced Constipation (OIC) Drugs, Date of Enter into This Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Opioid Induced Constipation (OIC) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Induced Constipation (OIC) Drugs as of 2024)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Opioid Induced Constipation (OIC) Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 19. Global Opioid Induced Constipation (OIC) Drugs Sales by Region (2020-2025) & (K Dose)
Table 20. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Region (2020-2025)
Table 21. Global Opioid Induced Constipation (OIC) Drugs Sales by Region (2026-2031) & (K Dose)
Table 22. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Region (2026-2031)
Table 23. Global Opioid Induced Constipation (OIC) Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 24. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Region (2020-2025)
Table 25. Global Opioid Induced Constipation (OIC) Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 26. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Region (2026-2031)
Table 27. North America Opioid Induced Constipation (OIC) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. North America Opioid Induced Constipation (OIC) Drugs Sales by Country (2020-2025) & (K Dose)
Table 29. North America Opioid Induced Constipation (OIC) Drugs Sales by Country (2026-2031) & (K Dose)
Table 30. North America Opioid Induced Constipation (OIC) Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 31. North America Opioid Induced Constipation (OIC) Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 32. Europe Opioid Induced Constipation (OIC) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 33. Europe Opioid Induced Constipation (OIC) Drugs Sales by Country (2020-2025) & (K Dose)
Table 34. Europe Opioid Induced Constipation (OIC) Drugs Sales by Country (2026-2031) & (K Dose)
Table 35. Europe Opioid Induced Constipation (OIC) Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 36. Europe Opioid Induced Constipation (OIC) Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 37. Asia Pacific Opioid Induced Constipation (OIC) Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 38. Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales by Region (2020-2025) & (K Dose)
Table 39. Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales by Region (2026-2031) & (K Dose)
Table 40. Asia Pacific Opioid Induced Constipation (OIC) Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 41. Asia Pacific Opioid Induced Constipation (OIC) Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 42. Latin America Opioid Induced Constipation (OIC) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Latin America Opioid Induced Constipation (OIC) Drugs Sales by Country (2020-2025) & (K Dose)
Table 44. Latin America Opioid Induced Constipation (OIC) Drugs Sales by Country (2026-2031) & (K Dose)
Table 45. Latin America Opioid Induced Constipation (OIC) Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 46. Latin America Opioid Induced Constipation (OIC) Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 47. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 48. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales by Country (2020-2025) & (K Dose)
Table 49. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales by Country (2026-2031) & (K Dose)
Table 50. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 51. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 52. Global Opioid Induced Constipation (OIC) Drugs Sales (K Dose) by Type (2020-2025)
Table 53. Global Opioid Induced Constipation (OIC) Drugs Sales (K Dose) by Type (2026-2031)
Table 54. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2020-2025)
Table 55. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2026-2031)
Table 56. Global Opioid Induced Constipation (OIC) Drugs Revenue (US$ Million) by Type (2020-2025)
Table 57. Global Opioid Induced Constipation (OIC) Drugs Revenue (US$ Million) by Type (2026-2031)
Table 58. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Type (2020-2025)
Table 59. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Type (2026-2031)
Table 60. Global Opioid Induced Constipation (OIC) Drugs Price (USD/Dose) by Type (2020-2025)
Table 61. Global Opioid Induced Constipation (OIC) Drugs Price (USD/Dose) by Type (2026-2031)
Table 62. Global Opioid Induced Constipation (OIC) Drugs Sales (K Dose) by Application (2020-2025)
Table 63. Global Opioid Induced Constipation (OIC) Drugs Sales (K Dose) by Application (2026-2031)
Table 64. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2020-2025)
Table 65. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2026-2031)
Table 66. Global Opioid Induced Constipation (OIC) Drugs Revenue (US$ Million) by Application (2020-2025)
Table 67. Global Opioid Induced Constipation (OIC) Drugs Revenue (US$ Million) by Application (2026-2031)
Table 68. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Application (2020-2025)
Table 69. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Application (2026-2031)
Table 70. Global Opioid Induced Constipation (OIC) Drugs Price (USD/Dose) by Application (2020-2025)
Table 71. Global Opioid Induced Constipation (OIC) Drugs Price (USD/Dose) by Application (2026-2031)
Table 72. Takeda Pharmaceuticals Company Information
Table 73. Takeda Pharmaceuticals Description and Business Overview
Table 74. Takeda Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 75. Takeda Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product
Table 76. Takeda Pharmaceuticals Recent Developments/Updates
Table 77. Bayer Company Information
Table 78. Bayer Description and Business Overview
Table 79. Bayer Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 80. Bayer Opioid Induced Constipation (OIC) Drugs Product
Table 81. Bayer Recent Developments/Updates
Table 82. Sanofi Company Information
Table 83. Sanofi Description and Business Overview
Table 84. Sanofi Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 85. Sanofi Opioid Induced Constipation (OIC) Drugs Product
Table 86. Sanofi Recent Developments/Updates
Table 87. Mallinckrodt Company Information
Table 88. Mallinckrodt Description and Business Overview
Table 89. Mallinckrodt Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 90. Mallinckrodt Opioid Induced Constipation (OIC) Drugs Product
Table 91. Mallinckrodt Recent Developments/Updates
Table 92. Salix (Bausch Health) Company Information
Table 93. Salix (Bausch Health) Description and Business Overview
Table 94. Salix (Bausch Health) Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 95. Salix (Bausch Health) Opioid Induced Constipation (OIC) Drugs Product
Table 96. Salix (Bausch Health) Recent Developments/Updates
Table 97. AstraZeneca Company Information
Table 98. AstraZeneca Description and Business Overview
Table 99. AstraZeneca Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 100. AstraZeneca Opioid Induced Constipation (OIC) Drugs Product
Table 101. AstraZeneca Recent Developments/Updates
Table 102. Progenics Pharmaceuticals Company Information
Table 103. Progenics Pharmaceuticals Description and Business Overview
Table 104. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 105. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product
Table 106. Progenics Pharmaceuticals Recent Developments/Updates
Table 107. Purdue Pharm Company Information
Table 108. Purdue Pharm Description and Business Overview
Table 109. Purdue Pharm Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 110. Purdue Pharm Opioid Induced Constipation (OIC) Drugs Product
Table 111. Purdue Pharm Recent Developments/Updates
Table 112. Nektar Therapeutics Company Information
Table 113. Nektar Therapeutics Description and Business Overview
Table 114. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 115. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Product
Table 116. Nektar Therapeutics Recent Developments/Updates
Table 117. Daiichi Sankyo Company Information
Table 118. Daiichi Sankyo Description and Business Overview
Table 119. Daiichi Sankyo Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 120. Daiichi Sankyo Opioid Induced Constipation (OIC) Drugs Product
Table 121. Daiichi Sankyo Recent Developments/Updates
Table 122. Prestige Company Information
Table 123. Prestige Description and Business Overview
Table 124. Prestige Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 125. Prestige Opioid Induced Constipation (OIC) Drugs Product
Table 126. Prestige Recent Developments/Updates
Table 127. GSK Company Information
Table 128. GSK Description and Business Overview
Table 129. GSK Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 130. GSK Opioid Induced Constipation (OIC) Drugs Product
Table 131. GSK Recent Developments/Updates
Table 132. Shionogi Company Information
Table 133. Shionogi Description and Business Overview
Table 134. Shionogi Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 135. Shionogi Opioid Induced Constipation (OIC) Drugs Product
Table 136. Shionogi Recent Developments/Updates
Table 137. Bausch Health Company Information
Table 138. Bausch Health Description and Business Overview
Table 139. Bausch Health Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 140. Bausch Health Opioid Induced Constipation (OIC) Drugs Product
Table 141. Bausch Health Recent Developments/Updates
Table 142. Zentiva Company Information
Table 143. Zentiva Description and Business Overview
Table 144. Zentiva Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 145. Zentiva Opioid Induced Constipation (OIC) Drugs Product
Table 146. Zentiva Recent Developments/Updates
Table 147. Orifarm A/S Company Information
Table 148. Orifarm A/S Description and Business Overview
Table 149. Orifarm A/S Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 150. Orifarm A/S Opioid Induced Constipation (OIC) Drugs Product
Table 151. Orifarm A/S Recent Developments/Updates
Table 152. Viatris Company Information
Table 153. Viatris Description and Business Overview
Table 154. Viatris Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 155. Viatris Opioid Induced Constipation (OIC) Drugs Product
Table 156. Viatris Recent Developments/Updates
Table 157. Endo International Company Information
Table 158. Endo International Description and Business Overview
Table 159. Endo International Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 160. Endo International Opioid Induced Constipation (OIC) Drugs Product
Table 161. Endo International Recent Developments/Updates
Table 162. Zhengdatianqing Company Information
Table 163. Zhengdatianqing Description and Business Overview
Table 164. Zhengdatianqing Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 165. Zhengdatianqing Opioid Induced Constipation (OIC) Drugs Product
Table 166. Zhengdatianqing Recent Developments/Updates
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Opioid Induced Constipation (OIC) Drugs Distributors List
Table 170. Opioid Induced Constipation (OIC) Drugs Customers List
Table 171. Opioid Induced Constipation (OIC) Drugs Market Trends
Table 172. Opioid Induced Constipation (OIC) Drugs Market Drivers
Table 173. Opioid Induced Constipation (OIC) Drugs Market Challenges
Table 174. Opioid Induced Constipation (OIC) Drugs Market Restraints
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
Table 178. Authors List of This Report
List of Figures
Figure 1. Product Picture of Opioid Induced Constipation (OIC) Drugs
Figure 2. Global Opioid Induced Constipation (OIC) Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Opioid Induced Constipation (OIC) Drugs Market Share by Type: 2024 & 2031
Figure 4. Lubiprostone Product Picture
Figure 5. Methyl Naltrexone Bromide Product Picture
Figure 6. Naldemedine Product Picture
Figure 7. Alvimopan Product Picture
Figure 8. Others Product Picture
Figure 9. Global Opioid Induced Constipation (OIC) Drugs Market Value Route of Administration, (US$ Million) & (2020-2031)
Figure 10. Global Opioid Induced Constipation (OIC) Drugs Market Share Route of Administration: 2024 VS 2031
Figure 11. Oral Formulations Product Picture
Figure 12. Injectable Formulations Product Picture
Figure 13. Suppositories / Enemas Product Picture
Figure 14. Other Product Picture
Figure 15. Global Opioid Induced Constipation (OIC) Drugs Market Value Chemical Class, (US$ Million) & (2020-2031)
Figure 16. Global Opioid Induced Constipation (OIC) Drugs Market Share Chemical Class: 2024 VS 2031
Figure 17. Peripheral µ-opioid Receptor Antagonists, Product Picture
Figure 18. Prokinetic Agents Product Picture
Figure 19. Bulk-forming Laxatives Product Picture
Figure 20. Other Product Picture
Figure 21. Small Molecule Product Picture
Figure 22. Peptide Product Picture
Figure 23. Selective 5-HT4 Receptor Agonist Product Picture
Figure 24. Global Opioid Induced Constipation (OIC) Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 25. Global Opioid Induced Constipation (OIC) Drugs Market Share by Application: 2024 & 2031
Figure 26. Hospital Pharmacies
Figure 27. Retail Pharmacies
Figure 28. Online Pharmacies
Figure 29. Global Opioid Induced Constipation (OIC) Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 30. Global Opioid Induced Constipation (OIC) Drugs Market Size (2020-2031) & (US$ Million)
Figure 31. Global Opioid Induced Constipation (OIC) Drugs Sales (2020-2031) & (K Dose)
Figure 32. Global Opioid Induced Constipation (OIC) Drugs Average Price (USD/Dose) & (2020-2031)
Figure 33. Opioid Induced Constipation (OIC) Drugs Report Years Considered
Figure 34. Opioid Induced Constipation (OIC) Drugs Sales Share by Manufacturers in 2024
Figure 35. Global Opioid Induced Constipation (OIC) Drugs Revenue Share by Manufacturers in 2024
Figure 36. Global 5 and 10 Largest Opioid Induced Constipation (OIC) Drugs Players: Market Share by Revenue in Opioid Induced Constipation (OIC) Drugs in 2024
Figure 37. Opioid Induced Constipation (OIC) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 38. Global Opioid Induced Constipation (OIC) Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 39. North America Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country (2020-2031)
Figure 40. North America Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country (2020-2031)
Figure 41. U.S. Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Canada Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country (2020-2031)
Figure 44. Europe Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country (2020-2031)
Figure 45. Germany Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. France Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. U.K. Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Italy Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Russia Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales Market Share by Region (2020-2031)
Figure 51. Asia Pacific Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Region (2020-2031)
Figure 52. China Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Japan Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. South Korea Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. India Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Australia Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Taiwan Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Indonesia Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Thailand Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 60. Malaysia Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 61. Philippines Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 62. Latin America Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country (2020-2031)
Figure 63. Latin America Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country (2020-2031)
Figure 64. Mexico Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 65. Brazil Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 66. Argentina Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 67. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country (2020-2031)
Figure 68. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country (2020-2031)
Figure 69. Turkey Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 70. Saudi Arabia Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 71. U.A.E Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 72. Global Sales Market Share of Opioid Induced Constipation (OIC) Drugs by Type (2020-2031)
Figure 73. Global Revenue Market Share of Opioid Induced Constipation (OIC) Drugs by Type (2020-2031)
Figure 74. Global Opioid Induced Constipation (OIC) Drugs Price (USD/Dose) by Type (2020-2031)
Figure 75. Global Sales Market Share of Opioid Induced Constipation (OIC) Drugs by Application (2020-2031)
Figure 76. Global Revenue Market Share of Opioid Induced Constipation (OIC) Drugs by Application (2020-2031)
Figure 77. Global Opioid Induced Constipation (OIC) Drugs Price (USD/Dose) by Application (2020-2031)
Figure 78. Opioid Induced Constipation (OIC) Drugs Value Chain
Figure 79. Channels of Distribution (Direct Vs Distribution)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global UV Delayed Curing Adhesives Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Die-Casting Die Steel Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Adaptive Neuromodulation Therapy Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232